논문KCI 등재
Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
대한감염학회 (The Korean Society Of Infectious Diseases)|2018.10|Infection and Chemotherapy|제50권 제3호|pp. 266-267
0
조회
0
다운로드
0
인용
0
참고문헌
주제분류내과학
참고문헌 (4)
- 김탁, "Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim", sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia, 2018, pp.50(2), 110~119[DOI]
- Smego RA Jr, "A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia", Arch Intern Med, 161, pp.1529~1533 (2001)
- Armstrong-James D, "A prognostic scoring tool for identification of patients at high and low risk of death from HIV-associated Pneumocystis jirovecii pneumonia", Int J STD AIDS, 22, pp.628~634 (2011)
- Kim T, "Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection", Scand J Infect Dis, 44, pp.670~677 (2012)
관련 논문AI추천
Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”이창훈대한감염학회 · Infection and Chemotherapy2018 · 제50권 제3호Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia김탁, 김성한, 김양수, 김태형, 성형섭, 우준희, 이상오, 정용필, 최상호, 추은주대한감염학회 · Infection and Chemotherapy2018 · 제50권 제2호Comparison of Clinical Characteristics of Pneumocystis Pneumonia with or without Human Immunodeficiency Virus: A Prognosis Contrary to Initial Clinical Features박윤선, 시혜진, 엄중식, 이주영, 홍신희연세대학교의과대학 · Yonsei Medical Journal2025 · 제66권 제11호Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from SputumKang Cheol-In대한감염학회 · Infection and Chemotherapy2021 · 제53권 제3호Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice강지영, 강혜선, 김석찬, 김승준, 김영균, 박연준, 이숙영, 이진국, 이혜연, 이화영대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제3호A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole조용균, Dong Hae Chung, Jeong-Woong Park, Sang Min Lee, Sang Pyo Lee, Sung Hwan Jeong, Yon Mi Sung대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2015 · 제53권 제3호
이 간행물의 다른 논문 (11건)
Diagnostic Methods for Prosthetic Joint Infection in Korea박경화, Robin Patelpp. 199-209Klebsiella pneumoniae Liver Abscess전재범pp. 210-218Journal Metrics of Infection & Chemotherapy and Current Scholarly Journal Publication Issues허선pp. 219-227The Predictive Value of Glycated Hemoglobin and Albumin for the Clinical Course Following Hospitalization of Patients with Febrile Urinary Tract InfectionGaku Nakamura, Toshitaka Uematsu, Takao Kamai, Minoru Kobayashi, Hironori Betsunoh, Tomoya Mizuno, Hidetoshi Kokubunpp. 228-237Analysis of Klebsiella as a Prognostic Factor of Ocular Outcomes in Endogenous Endophthalmitis with Decision Tree Analysis김신우, 김수정, 김윤정, 장현아, 이종명, 이상아, 황소윤, 정혜진pp. 238-251